デフォルト表紙
市場調査レポート
商品コード
1750652

北米の核酸分離・精製市場:市場規模・シェア・動向分析 (製品別・種類別・手法別・用途別・最終用途別・地域別)、セグメント別予測 (2025年~2030年)

North America Nucleic Acid Isolation And Purification Market Size, Share & Trends Analysis Report By Product, By Type, By Method, By Application, By End-use, By Country, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 120 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
北米の核酸分離・精製市場:市場規模・シェア・動向分析 (製品別・種類別・手法別・用途別・最終用途別・地域別)、セグメント別予測 (2025年~2030年)
出版日: 2025年05月22日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の核酸分離・精製市場の成長と動向:

北米の核酸分離・精製市場規模は、2025年から2030年にかけてCAGR 10.0%で成長し、2030年には41億5,000万米ドルに達すると予測されます。

この成長の原動力は、高度な分子診断に対する需要の増加、ゲノムおよび個別化医療に対する投資の増加、創薬および臨床研究用途の拡大です。正確な核酸分析を必要とする遺伝性疾患や感染症の流行の増加とともに、自動化やハイスループットシステムの技術的進歩が市場拡大に拍車をかけています。

さらに、精密農業と環境ゲノミクスに対する認識と採用の高まりが、核酸分離・精製市場の重要な成長促進要因として浮上しています。精密農業では、核酸技術が作物や土壌微生物の詳細な遺伝子解析を可能にし、収量、耐病性、持続可能性を向上させる。同様に、環境ゲノミクス・アプリケーションでは、生物多様性のモニタリングや生態系における病原体の検出が行われます。このような用途の拡大は、高度な核酸分離ツールに対する新たな需要を生み出し、従来のヘルスケアや研究分野にとどまらない市場の広がりをもたらしています。産業界が資源や環境管理を最適化するための遺伝学的洞察の価値を認識するにつれて、市場の成長はさらに加速されます。

しかし、高度な自動核酸分離システムと消耗品に関連する高コストは、特に小規模ラボや新興市場にとって大きな抑制要因となっています。さらに、特定の技術の複雑さや専門的なトレーニングの必要性が、普及を制限する可能性があります。規制上の課題や厳格なコンプライアンス要件は、市場の拡大をさらに遅らせます。これらの要因は、核酸精製ソリューションの需要が高まっているにもかかわらず、アクセスしやすさと手頃な価格の妨げとなり、成長を抑制しています。

北米の核酸分離・精製市場レポート・ハイライト

  • 製品別では、キット・試薬が2024年に最大の市場シェアを占めました。これは、使いやすさと研究・診断への幅広い応用に起因します。継続的な技術革新と費用対効果が、その普及をさらに後押ししています。機器部門は予測期間中に最も急成長する見込みです。
  • DNA分離・精製セグメントは、2024年に種類別の市場シェアを独占し、予測期間中に最も速いCAGRで成長すると予測されています。この背景には、ゲノム研究、臨床診断、バイオ医薬品開発におけるDNA分析の需要増加があります。しかし、RNA単離・精製は予測期間中にCAGRで大きく成長すると予測されています。
  • 用途別では、創薬・薬剤開発が2024年に35.76%の最大市場シェアを占め、予測期間中に最も速いCAGRで成長すると予測されます。研究開発投資の増加、標的同定のための核酸分析利用の増加、精密医療とバイオマーカー探索の需要の高まりがこれを後押ししています。しかし、精密医療は予測期間中にCAGRが大きく伸びると予測されています。
  • 磁気ビーズのセグメントは、2024年に最大のシェアでメソッドセグメントを支配し、予測期間中に最も速いCAGRで成長すると予測されています。この成長は、その高い効率性、拡張性、迅速で純粋な核酸分離を実現する能力によるもので、ハイスループットや自動化用途に最適です。しかし、カラムベースの方法は予測期間中に大きく成長する見込みです。
  • 病院・診断センターのセグメントは、2024年に最大のシェアを占め、最終用途セグメントを支配しました。この成長は、核酸ベースの診断検査の採用が増加していること、感染症や遺伝病の有病率が上昇していること、地域全体で臨床検査インフラが拡大していることに起因しています。しかし、製薬&バイオテクノロジー企業は、予測期間中に最も高い成長率で成長すると予測されています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 北米の核酸分離・精製市場:変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • 北米の核酸分離・精製市場:分析ツール
    • 業界分析:ポーターのファイブフォース分析
    • PESTEL分析

第4章 北米の核酸分離・精製市場:製品別の推定・動向分析

  • 製品別のダッシュボード
  • 北米の核酸分離・精製市場:製品別の変動分析
  • 北米の核酸分離・精製市場:市場規模の予測と動向分析、製品別 (2018~2030年)
  • キット・試薬
    • キット・試薬の市場規模・予測・動向分析(2018年~2030年)
  • 機器
    • 機器市場規模と予測および動向分析、2018~2030年
    • 手動式
    • 自動式

第5章 北米の核酸分離・精製市場:種類別の推定・動向分析

  • 種類別のダッシュボード
  • 北米の核酸分離・精製市場:種類別の変動分析
  • 北米の核酸分離・精製市場:市場規模の予測と動向分析、種類別 (2018~2030年)
  • DNA分離・精製
    • DNA分離・精製の市場規模・予測・動向分析(2018年~2030年)
    • ゲノムDNAの分離・精製
    • プラスミドDNAの分離・精製
    • ウイルスDNAの分離・精製
    • その他
  • RNA分離・精製
    • RNA分離・精製の市場規模・予測・動向分析(2018年~2030年)
    • miRNAの分離・精製
    • mRNAの分離・精製
    • 全RNAの分離・精製
    • その他

第6章 北米の核酸分離・精製市場:用途別の推定・動向分析

  • 用途別のダッシュボード
  • 北米の核酸分離・精製市場:用途別の変動分析
  • 北米の核酸分離・精製市場:市場規模の予測と動向分析、用途別 (2018~2030年)
  • 精密医療
    • 精密医療の市場規模・予測・動向分析(2018年~2030年)
  • 診断
    • 診断の市場規模・予測・動向分析(2018年~2030年)
  • 創薬・薬剤開発
    • 創薬・薬剤開発の市場規模・予測・動向分析(2018年~2030年)
  • 農業・動物研究
    • 農業・動物研究の市場規模・予測・動向分析(2018年~2030年)
  • その他の用途
    • その他の用途の市場規模・予測・動向分析(2018年~2030年)

第7章 北米の核酸分離・精製市場:手法別の推定・動向分析

  • 手法別のダッシュボード
  • 北米の核酸分離・精製市場:手法別の変動分析
  • 北米の核酸分離・精製市場:市場規模の予測と動向分析、手法別 (2018~2030年)
  • コラムベース
    • コラムベースの市場規模・予測・動向分析(2018年~2030年)
  • 磁気ビーズ
    • 磁気ビーズの市場規模・予測・動向分析(2018年~2030年)
  • 試薬ベース
    • 試薬ベースの市場規模・予測・動向分析(2018年~2030年)
  • その他
    • その他の市場規模・予測・動向分析(2018年~2030年)

第8章 北米の核酸分離・精製市場:最終用途別の推定・動向分析

  • 最終用途別のダッシュボード
  • 北米の核酸分離・精製市場:最終用途別の変動分析
  • 北米の核酸分離・精製市場:市場規模の予測と動向分析、最終用途別 (2018~2030年)
  • 学術調査機関
    • 学術調査機関の市場規模と予測および動向分析、2018~2030年
  • 製薬・バイオテクノロジー企業
    • 製薬・バイオテクノロジー企業の市場規模・予測・動向分析(2018年~2030年)
  • CRO(医薬品開発業務受託機関)
    • CROの市場規模・予測・動向分析(2018年~2030年)
  • 病院・診断センター
    • 病院・診断センターの市場規模・予測・動向分析(2018年~2030年)
  • その他の最終用途
    • その他の最終用途の市場規模・予測・動向分析(2018年~2030年)

第9章 北米の核酸分離・精製市場:国別の推定・動向分析

  • 市場シェア分析:国別 (2024年・2030年)
  • 市場ダッシュボード:国別
  • 米国
    • 主要国の動向
    • 規制の枠組み
    • 競合シナリオ
  • カナダ
    • 主要国の動向
    • 規制の枠組み
    • 競合シナリオ
  • メキシコ
    • 主要国の動向
    • 規制の枠組み
    • 競合シナリオ

第10章 競合情勢

  • 参入企業
  • 企業市況分析(2024年)
  • 戦略マッピング
  • 参入企業概要
    • サーモフィッシャーサイエンティフィック株式会社
    • キアゲン
    • メルクKGaA
    • イルミナ株式会社
    • ダナハー
    • F.ホフマン・ラ・ロシュ株式会社
    • アジレントテクノロジー
    • バイオ・ラッド・ラボラトリーズ社
    • タカラバイオ株式会社
    • プロメガ株式会社
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Nucleic Acid Isolation & Purification Market, by Country, 2018 - 2030 (USD Million)
  • Table 3 North America Nucleic Acid Isolation & Purification Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 North America Nucleic Acid Isolation & Purification Market, by Type, 2018 - 2030 (USD Million)
  • Table 5 North America Nucleic Acid Isolation & Purification Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 North America Nucleic Acid Isolation & Purification Market, by Method, 2018 - 2030 (USD Million)
  • Table 7 North America Nucleic Acid Isolation & Purification Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Nucleic Acid Isolation & Purification Market, by Product, 2018 - 2030 (USD Million)
  • Table 9 U.S. Nucleic Acid Isolation & Purification Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Nucleic Acid Isolation & Purification Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 U.S. Nucleic Acid Isolation & Purification Market, by Method, 2018 - 2030 (USD Million)
  • Table 12 U.S. Nucleic Acid Isolation & Purification Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 Canada Nucleic Acid Isolation & Purification Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 Canada Nucleic Acid Isolation & Purification Market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Nucleic Acid Isolation & Purification Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Nucleic Acid Isolation & Purification Market, by Method, 2018 - 2030 (USD Million)
  • Table 17 Canada Nucleic Acid Isolation & Purification Market, by End Use, 2018 - 2030 (USD Million)
  • Table 18 Mexico Nucleic Acid Isolation & Purification Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Mexico Nucleic Acid Isolation & Purification Market, by Type, 2018 - 2030 (USD Million)
  • Table 20 Mexico Nucleic Acid Isolation & Purification Market, by Application, 2018 - 2030 (USD Million)
  • Table 21 Mexico Nucleic Acid Isolation & Purification Market, by Method, 2018 - 2030 (USD Million)
  • Table 22 Mexico Nucleic Acid Isolation & Purification Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Market formulation & Validation
  • Fig. 6 North America Nucleic Acid Isolation & Purification Market: Market Outlook
  • Fig. 7 Parent Market Outlook
  • Fig. 8 Related/Ancillary Market Outlook
  • Fig. 9 Penetration and Growth Prospect Mapping
  • Fig. 10 Industry Value Chain Analysis
  • Fig. 11 North America Nucleic Acid Isolation & Purification Market Driver Impact
  • Fig. 12 North America Nucleic Acid Isolation & Purification Market Restraint Impact
  • Fig. 13 North America Nucleic Acid Isolation & Purification Market Strategic Initiatives Analysis
  • Fig. 14 North America Nucleic Acid Isolation & Purification Market: Product Movement Analysis
  • Fig. 15 North America Nucleic Acid Isolation & Purification Market: Product Outlook and Key Takeaways
  • Fig. 16 Kits & Reagents Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Instruments Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Manual Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Automatic Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 20 North America Nucleic Acid Isolation & Purification Market: Type Movement Analysis
  • Fig. 21 North America Nucleic Acid Isolation & Purification Market: Type Outlook and Key Takeaways
  • Fig. 22 DNA Isolation & Purification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Genomic DNA Isolation & Purification Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Plasmid DNA Isolation & Purification Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Viral DNA Isolation & Purification Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Other Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 27 RNA Isolation & Purification Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 28 miRNA Isolation & Purification Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 29 mRNA Isolation & Purification Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Total RNA Isolation & Purification Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Other Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 32 North America Nucleic Acid Isolation & Purification Market: Application Movement Analysis
  • Fig. 33 North America Nucleic Acid Isolation & Purification Market: Application Outlook and Key Takeaways
  • Fig. 34 Precision Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Drug Discovery & Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Agriculture and Animal Research Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Other Applications Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 North America Nucleic Acid Isolation & Purification Market: Method Movement Analysis
  • Fig. 40 North America Nucleic Acid Isolation & Purification Market: Method Outlook and Key Takeaways
  • Fig. 41 Column-based Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Magnetic Beads Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Reagent-based Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 North America Nucleic Acid Isolation & Purification Market: End Use Movement Analysis
  • Fig. 46 North America Nucleic Acid Isolation & Purification Market: End Use Outlook and Key Takeaways
  • Fig. 47 Academic Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Contract Research Organizations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Hospitals and Diagnostic Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 North America Nucleic Acid Isolation & Purification Market: Country Movement Analysis
  • Fig. 53 North America Nucleic Acid Isolation & Purification Market: Country Outlook and Key Takeaways
  • Fig. 54 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 U.S. Country Dynamics
  • Fig. 56 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Canada Country Dynamics
  • Fig. 58 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico Country Dynamics
  • Fig. 60 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-590-0

North America Nucleic Acid Isolation & Purification Market Growth & Trends:

The North America nucleic acid isolation and purification market size is expected to reach USD 4.15 billion by 2030, growing at a CAGR of 10.0% from 2025 to 2030. This growth is driven by the increasing demand for advanced molecular diagnostics, rising investments in genomics and personalized medicine, and expanding drug discovery and clinical research applications. Technological advancements in automation and high-throughput systems fuel market expansion, alongside the growing prevalence of genetic disorders and infectious diseases that require accurate nucleic acid analysis.

Moreover, growing awareness and adoption of precision agriculture and environmental genomics are emerging as important growth drivers for the nucleic acid isolation and purification market. In precision agriculture, nucleic acid technologies enable detailed genetic analysis of crops and soil microbiomes, improving yield, disease resistance, and sustainability. Similarly, environmental genomics applications involve monitoring biodiversity and detecting pathogens in ecosystems. These expanding uses create new demand for advanced nucleic acid isolation tools, broadening the market beyond traditional healthcare and research sectors. As industries recognize the value of genetic insights for optimizing resources and environmental management, market growth is further accelerated.

However, the high costs associated with advanced automated nucleic acid isolation systems and consumables pose a significant restraint, particularly for smaller laboratories and emerging markets. Additionally, the complexity of specific technologies and the need for specialized training can limit widespread adoption. Regulatory challenges and strict compliance requirements further slow market expansion. These factors collectively hinder accessibility and affordability, restricting growth despite rising demand for nucleic acid purification solutions.

North America Nucleic Acid Isolation And Purification Market Report Highlights:

  • Based on product, the kits & reagents held the largest market share in 2024. This is attributed to their ease of use and broad application in research and diagnostics. Continuous innovation and cost-effectiveness further support their widespread adoption. The instruments segment is expected to grow fastest over the forecast period.
  • The DNA isolation & purification segment dominated the type market share in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This is driven by increasing demand for DNA analysis in genomics research, clinical diagnostics, and biopharmaceutical development. However, RNA isolation & purification are anticipated to grow at a significant CAGR over the forecast period.
  • The drug discovery & development as an application held the largest market share of 35.76% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. Rising R&D investments, increased use of nucleic acid analysis for target identification, and the growing demand for precision medicine and biomarker discovery drive this. However, Precision Medicine is anticipated to grow at a significant CAGR over the forecast period.
  • The magnetic beads segment dominated the method segment with the largest share in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This growth is attributed to its high efficiency, scalability, and ability to deliver rapid, pure nucleic acid isolation, making it ideal for high-throughput and automated applications. However,column-based methods are expected to grow significantly over the forecast period.
  • The hospitals and diagnostic centers segment dominated the end use segment with the largest share in 2024. This growth is attributed to the increasing adoption of nucleic acid-based diagnostic tests, the rising prevalence of infectious and genetic diseases, and the expanding clinical testing infrastructure across the region. However,pharmaceutical & biotechnology companies are expected to grow at the highest rate over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. Application
    • 1.2.4. Method
    • 1.2.5. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America Nucleic Acid Isolation & Purification Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of cancer, genetic disorders, and infectious diseases
      • 3.2.1.2. Increase in public-private funding for biotechnology and life science research
      • 3.2.1.3. Advancements in automation
      • 3.2.1.4. Growth in NGS technologies
      • 3.2.1.5. Growing demand for genetically modified crops and organisms
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Expensive instruments and consequent low penetration in emerging countries
      • 3.2.2.2. Challenges related to the use of big data and bioinformatics
  • 3.3. North America Nucleic Acid Isolation & Purification Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. North America Nucleic Acid Isolation & Purification Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. North America Nucleic Acid Isolation & Purification Market Product Movement Analysis
  • 4.3. North America Nucleic Acid Isolation & Purification Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Kits & Reagents
    • 4.4.1. Kits & Reagents Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5. Instrument
    • 4.5.1. Instrument Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.5.2. Manual
      • 4.5.2.1. Manual Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.5.3. Automatic
      • 4.5.3.1. Automatic Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. North America Nucleic Acid Isolation & Purification Market: Type Estimates & Trend Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. North America Nucleic Acid Isolation & Purification Market Type Movement Analysis
  • 5.3. North America Nucleic Acid Isolation & Purification Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. DNA Isolation & Purification
    • 5.4.1. DNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.4.2. Genomic DNA Isolation & Purification
      • 5.4.2.1. Genomic DNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.4.3. Plasmid DNA Isolation & Purification
      • 5.4.3.1. Plasmid DNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.4.4. Viral DNA Isolation & Purification
      • 5.4.4.1. Viral DNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.4.5. Other
      • 5.4.5.1. Other Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.5. RNA Isolation & Purification
    • 5.5.1. RNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.5.2. miRNA Isolation & Purification
      • 5.5.2.1. miRNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.5.3. mRNA Isolation & Purification
      • 5.5.3.1. mRNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.5.4. Total RNA Isolation & Purification
      • 5.5.4.1. Total RNA Isolation & Purification Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 5.5.5. Other
      • 5.5.5.1. Other Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. North America Nucleic Acid Isolation & Purification Market: Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. North America Nucleic Acid Isolation & Purification Market Application Movement Analysis
  • 6.3. North America Nucleic Acid Isolation & Purification Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Precision Medicine
    • 6.4.1. Precision Medicine Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 6.5. Diagnostics
    • 6.5.1. Diagnostics Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 6.6. Drug Discovery & Development
    • 6.6.1. Drug Discovery & Development Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 6.7. Agriculture and Animal Research
    • 6.7.1. Agriculture and Animal Research Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 6.8. Other Applications
    • 6.8.1. Other Applications Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 7. North America Nucleic Acid Isolation & Purification Market: Method Estimates & Trend Analysis

  • 7.1. Method Segment Dashboard
  • 7.2. North America Nucleic Acid Isolation & Purification Market Method Movement Analysis
  • 7.3. North America Nucleic Acid Isolation & Purification Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
  • 7.4. Column-based
    • 7.4.1. Column-based Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 7.5. Magnetic Beads
    • 7.5.1. Magnetic Beads Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 7.6. Reagent-based
    • 7.6.1. Reagent-based Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 8. North America Nucleic Acid Isolation & Purification Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Segment Dashboard
  • 8.2. North America Nucleic Acid Isolation & Purification Market End Use Movement Analysis
  • 8.3. North America Nucleic Acid Isolation & Purification Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Academic Research Institutes
    • 8.4.1. Academic Research Institutes Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 8.5. Pharmaceutical & Biotechnology Companies
    • 8.5.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 8.6. Contract Research Organizations
    • 8.6.1. Contract Research Organizations Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 8.7. Hospitals and Diagnostic Centers
    • 8.7.1. Hospitals and Diagnostic Centers Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 8.8. Other End Use
    • 8.8.1. Other End Use Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 9. North America Nucleic Acid Isolation & Purification Market: Country Estimates & Trend Analysis

  • 9.1. Country Market Share Analysis, 2024 & 2030
  • 9.2. Country Market Dashboard
  • 9.3. U.S.
    • 9.3.1. Key country dynamics
    • 9.3.2. Regulatory framework
    • 9.3.3. Competitive scenario
    • 9.3.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4. Canada
    • 9.4.1. Key country dynamics
    • 9.4.2. Regulatory framework
    • 9.4.3. Competitive scenario
    • 9.4.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Mexico
    • 9.5.1. Key country dynamics
    • 9.5.2. Regulatory framework
    • 9.5.3. Competitive scenario
    • 9.5.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Categorization
  • 10.2. Company Market Position Analysis, 2024
  • 10.3. Strategy Mapping
  • 10.4. Participants Overview
    • 10.4.1. Thermo Fisher Scientific, Inc.
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. QIAGEN
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Merck KGaA
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Illumina, Inc.
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Danaher
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. F. Hoffmann-La Roche Ltd.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Agilent Technologies
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Bio-Rad Laboratories, Inc
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Takara Bio Inc.
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Promega Corporation
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives